Can a person develop an allergic reaction to corticosteroids?

Can You Have an Allergy to Steroids?

Yes, corticosteroids can paradoxically cause both immediate and delayed hypersensitivity reactions, despite their anti-inflammatory properties, and these reactions are clinically important because they are often difficult to distinguish from worsening of the underlying disease being treated. 1, 2

Types of Corticosteroid Hypersensitivity Reactions

Corticosteroid hypersensitivity reactions fall into two main categories:

Immediate Reactions (Within 1 Hour)

• IgE-mediated anaphylaxis can occur, with an estimated prevalence of 0.3–0.5% in the general population, though rates are higher in patients receiving repeated corticosteroid doses. 2
• Immediate reactions typically manifest as urticaria, angioedema, bronchospasm, or anaphylaxis within 15–60 minutes of administration. 1, 3, 2
• These reactions may be triggered by the corticosteroid molecule itself or by excipients such as carboxymethylcellulose or polyethylene glycol (PEG) in injectable formulations. 4, 5

Delayed Reactions (More Than 1 Hour After Administration)

• Delayed hypersensitivity is more common than immediate reactions and includes maculopapular rash, acute generalized exanthematous pustulosis (AGEP), and systemic contact dermatitis. 1, 2, 6
• Patients with prior allergic contact dermatitis from topical corticosteroids are at risk for systemic contact dermatitis when receiving oral or intravenous corticosteroids, though prior sensitization is not mandatory. 4, 6
• Atopic dermatitis and stasis dermatitis are specific risk factors for developing allergic contact dermatitis from topical corticosteroids. 2

Diagnostic Approach

For Immediate Hypersensitivity

• Prick and intradermal skin tests are the primary diagnostic tools for immediate reactions, though standardization remains incomplete. 1, 2
• Intradermal testing should use a limited volume (0.02 mL) to minimize the risk of transient skin atrophy, though prospective studies are needed to fully characterize this risk. 4

For Delayed Hypersensitivity

• Patch testing is the diagnostic method of choice for delayed reactions, with readings at days 2,4, and 7. 1, 4
• Testing should be performed when the patient's underlying condition is in a quiescent state to avoid confounding the interpretation. 2

Critical Diagnostic Challenge

• The most difficult aspect of diagnosis is distinguishing true hypersensitivity from deterioration of the underlying inflammatory disease (e.g., worsening asthma or dermatitis), requiring a high index of suspicion. 1

Cross-Reactivity Patterns

Cross-reactivity between corticosteroids is unpredictable and does not reliably follow chemical classification systems:

• The Baeck classification dividing corticosteroids into three chemical groups may explain cross-reactivity in contact dermatitis but does not apply to systemic hypersensitivity reactions. 4
• In the literature, 52 of 79 patients (66%) who reacted to one corticosteroid group tolerated a different corticosteroid from the same chemical group on provocation testing, demonstrating that chemical structure does not predict safety. 4
• Provocation testing is necessary to identify a safe alternative corticosteroid, even within the same chemical group, when skin tests are negative and the initial reaction was non-severe. 4

Management Algorithm

Step 1: Confirm True Hypersensitivity

• Obtain a detailed history to differentiate hypersensitivity from disease progression or excipient reactions (especially PEG in injectable formulations). 5, 1
• Consider PEG allergy if the patient has had repeated anaphylactic reactions to ≥2 structurally different medications sharing PEG as an excipient. 5

Step 2: Identify an Alternative Corticosteroid

• Perform skin testing (prick/intradermal for immediate reactions, patch testing for delayed reactions) with alternative corticosteroids from different chemical groups. 1, 4, 2
• If skin tests are negative, proceed to supervised provocation testing to confirm tolerance before prescribing the alternative. 4
• Dexamethasone has been successfully used as an alternative in patients with methylprednisolone hypersensitivity, including in transplant recipients. 3

Step 3: Avoid Excipient-Mediated Reactions

• If the reaction is suspected to be excipient-mediated (e.g., PEG or carboxymethylcellulose), switch to a formulation without that excipient rather than avoiding all corticosteroids. 5, 4
• For PEG-allergic patients, methylprednisolone sodium succinate may be tolerated if the reaction was to methylprednisolone acetate (which contains PEG). 5

Step 4: Document and Educate

• Clearly document the specific corticosteroid and formulation that caused the reaction, along with all synonyms, to prevent inadvertent re-exposure. 5
• Educate the patient on recognizing symptoms and the importance of informing all healthcare providers about the allergy. 5, 2

Common Pitfalls to Avoid

• Do not assume all corticosteroids are cross-reactive: Chemical structure does not predict cross-reactivity in systemic hypersensitivity, and most patients tolerate alternative corticosteroids from the same chemical group. 4
• Do not attribute worsening symptoms solely to disease progression: Always consider corticosteroid hypersensitivity when a patient's condition deteriorates despite treatment, especially if new cutaneous or respiratory symptoms appear. 1, 6
• Do not use depot parenteral corticosteroids for allergic conditions: These formulations carry additional risks and are not recommended for allergic rhinitis or similar conditions. 7
• Do not rely on corticosteroids to prevent biphasic anaphylaxis: There is no compelling evidence that corticosteroids reduce anaphylaxis severity or prevent biphasic reactions, and their routine use in anaphylaxis is not advocated. 8

Special Considerations for High-Risk Patients

• Patients receiving repeated corticosteroid doses (e.g., transplant recipients, those with severe asthma) are at higher risk for developing hypersensitivity. 2
• In life-saving situations where corticosteroids are essential, allergologic evaluation and identification of a safe alternative must be prioritized. 2, 6
• Testing should be deferred until the patient's condition is stable to ensure accurate interpretation of results. 2